Valuation: Boston Scientific Corporation

Market Cap 66.22B 59.13B 54.62B 49.5B 92.61B 6,286B 94.14B 657B 260B 3,293B 248B 243B 10,383B P/E 2026 *
17.3x
P/E 2027 * 18.1x
Enterprise Value 72.63B 64.85B 59.91B 54.29B 102B 6,894B 103B 721B 285B 3,612B 273B 267B 11,388B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.24x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-0.25%
1 week+1.07%
Current month+4.31%
1 month+3.22%
3 months+0.04%
6 months-24.05%
Current year-52.25%
1 week 43.92
Extreme 43.915
46.16
1 month 41.38
Extreme 41.385
46.16
Current year 41.38
Extreme 41.385
100.9
1 year 41.38
Extreme 41.385
105.65
3 years 41.38
Extreme 41.385
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Buy

Director

2,040 0.0001%
11/8/26 Other

Controller/Auditor

2,930 0.0002%
10/8/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+1.07%-55.55%-8.54% 66.22B
+0.61%+0.41%+21.00%+54.98% 249B
+0.74%+3.87%+5.47%+20.36% 162B
+0.43%+4.71%-17.72%+74.78% 157B
-0.55%+1.22%+8.44%+68.64% 52.3B
+0.82%+3.00%-14.59%-8.35% 52.18B
+1.05%+2.95%+11.10%+43.03% 51.34B
+1.55%+3.68%+20.17%+68.87% 48.79B
+1.00%+5.83%+30.66%+88.01% 44.57B
+0.90%+3.75%+171.57%+144.13% 40.68B
Average +0.66%+2.17%+18.06%+54.59% 92.42B
Weighted average by Cap. +0.70%+1.46%+10.00%+50.50%

Financials

2026 *2027 *
Net sales 21.13B 18.87B 17.43B 15.79B 29.55B 2,005B 30.04B 210B 83.03B 1,051B 79.28B 77.6B 3,313B 22.14B 19.77B 18.26B 16.55B 30.96B 2,101B 31.47B 220B 87B 1,101B 83.07B 81.31B 3,471B
Net income 3.75B 3.35B 3.1B 2.81B 5.25B 356B 5.34B 37.26B 14.75B 187B 14.08B 13.79B 588B 3.68B 3.28B 3.03B 2.75B 5.14B 349B 5.23B 36.49B 14.45B 183B 13.79B 13.5B 576B
Net Debt 6.41B 5.72B 5.29B 4.79B 8.97B 609B 9.11B 63.64B 25.19B 319B 24.06B 23.55B 1,005B 5.49B 4.91B 4.53B 4.11B 7.69B 522B 7.81B 54.55B 21.6B 273B 20.62B 20.18B 862B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
27/10/26 USD 45.54 -0.34% 3,534,228
23/10/26 USD 45.69 -0.70% 8,772,772
22/10/26 USD 46.01 +3.37% 16,395,574
21/10/26 USD 44.51 -2.35% 15,193,231
20/10/26 USD 45.58 +1.18% 16,013,159
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
45.69USD
Average target price
57.82USD
Spread / Average Target
+26.55%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation